Importance of the terminal portion of tumor time-activity curve in determining tumor dosimetry in radioimmunotherapy.
Wahl
R L
RL
Zasadny
K
K
Kaminski
M S
MS
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell / Q000628:therapy*; D011879:Radiotherapy Dosage
D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes